© 1986 British Society for Rheumatology
research-article |
PRELIMINARY EVIDENCE FOR GUT INVOLVEMENT IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS?
1Department of Haematology, the Faculty of Clinical Sciences, University College London WC1, UK
2Department of Rheumatology and Rehabilitation, the Faculty of Clinical Sciences, University College London WC1, UK
3Department of Medical Physics, the Faculty of Clinical Sciences, University College London WC1, UK
Correspondence to:
Address correspondence to Dr. A. W. Segal
111Indium leucocyte scans were performed on 26 patients with active rheumatoid arthritis. An abnormal localization of radioactivity was observed in the gut of 12 of these patients, generally in the region of the terminal ileum, caecum and ascending colon. No difference was found in the intake of nonsteroidal anti-inflammatory drugs between those with positive and negative scans. Two patients with positive scans were on no medication. These observations suggest the possibility of a primary role for a gastrointestinal lesion in the aetiology of rheumatoid arthritis, although these abnormalities could be secondary or unrelated.
KEY WORDS: Gut, Rheumatoid arthritis, Indium leucocyte scan
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Podas, J. M D Nightingale, R. Oldham, S Roy, N. J Sheehan, and J. F Mayberry Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone Postgrad. Med. J., February 1, 2007; 83(976): 128 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Z A Leite, A M Sipahi, A O M C Damiao, A M M Coelho, A T Garcez, M C C Machado, C A Buchpiguel, F P Lopasso, M L Lordello, C L O Agostinho, et al. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism Gut, February 1, 2001; 48(2): 163 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Sigthorsson, R Crane, T Simon, M Hoover, H Quan, J Bolognese, and I Bjarnason COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin Gut, October 1, 2000; 47(4): 527 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Tibble, G Sigthorsson, R Foster, D Scott, M K Fagerhol, A Roseth, and I Bjarnason High prevalence of NSAID enteropathy as shown by a simple faecal test Gut, September 1, 1999; 45(3): 362 - 366. [Abstract] [Full Text] [PDF] |
||||

